Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2016

01-08-2016 | Case Report

Resolution of Isolated, Aspergillus Colonization in a Deep Esophageal Ulcer in an Immunocompetent Patient with Ulcer Healing Without Specific Antifungal Therapy

Authors: Mitchell S. Cappell, Dupinder Singh, Ross Sage, Mitual B. Amin

Published in: Digestive Diseases and Sciences | Issue 8/2016

Login to get access

Excerpt

Isolated gastrointestinal (GI) aspergillosis is relatively rare with only 18 previously reported cases, and in all these cases, the Aspergillus infection was invasive and occurred in immunosuppressed patients (Table 1; [111]). A case is reported of isolated, superficial, Aspergillus GI infection with novel features including: (1) Aspergillus colonizing a deep esophageal ulcer without tissue invasion, (2) this colonization occurring in an immunocompetent patient, and (3) resolution of the colonization with antiulcer therapy without antifungal therapy.
Table 1
Clinical presentation, diagnosis, treatment, and outcome in the 18 previously reported cases of isolated gastrointestinal aspergillosis
Reference: first author, year
Age in years, sex
Clinical presentation
Underlying immunosuppression
Leukocyte count, ANC (109/L)
Lesion location type
Diagnosis
Medical or surgical treatment
Patient outcome
Esophageal lesions
1. Current report
52, M
Dysphagia, weight loss
None
 
Esophagus-deep ulcer
EGD and biopsy: superficial, truly septated hyphae with acute-angle branching consistent with Aspergillus (colonization)
Oral omeprazole
Survived, no recurrence during 8 months of follow-up
2. Erikci 2009 [1]
18, M
Dysphagia, retrosternal pain
ALL
0.4, 0
Esophagus-erosions
EGD: esophageal erosions, Biopsy: Aspergillus
IV amphotericin B and caspofungin
Symptoms resolved
3. Alioglu 2007 [2]
15, M
Dysphagia and vomiting
AML
NR, NR
Esophagus-ulcers and stenosis
EGD and biopsy: fungal hyphae with acute-angle branching
IV amphotericin B and caspofungin, G-CSF
Survived
4. Bergman 2004 [3]
79, F
NR
AML
NR, NR
Esophagitis
EGD and esophageal brushing cytology: fungal organisms consistent with Aspergillus
NR
Expired 1 week later
5. Chionh 2005 [4]
71, M
Epigastric pain and hematemesis
AML
92.5, 0.25
Esophagus-exophytic lesion
EGD and biopsy: fungal hyphae and yeast forms consistent with Aspergillus
Oral voriconazole, G-CSF
Survived
6. Choi 1997 [5]
35, M
Nausea, vomiting, and odynophagia
AML status post allogenic bone marrow transplant
5.5, NR
Esophagus-ulcer
EGD: shallow esophageal ulcer, biopsy: dichotomously branching septate hyphae consistent with Aspergillus
IV amphotericin B
Symptoms resolved
7. Yoo [6]
50, M
Odynophagia
AML
15.8, 3
Esophagus-mass
EGD and biopsy: dichotomously branching septate hyphae strongly suggesting Aspergillus
IV amphotericin B
Survived, resolution of mass after 1 month
Gastric lesions
8. Kazan 2011 [7]
51, M
NR
Multiple myeloma
NR, >0.5
Stomach
EGD: fungal culture positive for Aspergillus
Surgery
Died at day 17
Small intestinal lesions
9. Kazan 2011 [7]
56, F
NR
AML
NR, <0.5
Duodenum
EGD: fungal culture positive for Aspergillus
Surgery
Survived
10. Kazan 2011 [7]
70, F
NR
AML
NR, <0.5
Duodenum
Fungal culture negative
Laparotomy
Survived
11. Eggimann 2006 [8]
52, M
Abdominal pain, septic shock
AML (transformed from myelodysplasia)
NR, <0.5
Ileum masses
Biopsy and culture positive for Aspergillus
Laparotomy, IV amphotericin B
Expired 2 months later
12. Trésallet 2004 [9]a
57, NR
Persistent fever, peritonitis
Lymphoma
NR, <0.5
Ileum necrosis
Histology and culture positive for Aspergillus
Bowel excision, voriconazole
Survived
13. Gonzalez 2008 [10]
19, M
Abdominal pain and GI bleeding
Wilm’s tumor, Autologous PBSCT
NR, NR
Small bowel ulcer
Biopsy: septate hyphae with acute-angle branching, Fungal culture: positive for Aspergillus fumigatus
Laparotomy with ileal resection, G-CSF
Expired few hours later
14. Kazan 2011 [7]
54, F
NR
AML
NR, <0.5
Small bowel
NR
Laparotomy
Died on day of surgery
15. Marterre 1992 [11]
9, M
Fever, ileus, peritonitis, small bowel obstruction
ALL
NR, >0.5
Small bowel
Histology and culture positive for Aspergillus
Bowel excision
Survived
Colonic and appendiceal lesions
16. Kazan 2011 [7]
19, M
NR
AML
NR, <0.5
Appendix
NR
Laparotomy
Survived
17. Kazan 2011 [7]
62, F
NR
AML
NR, >0.5
Colon
Colonoscopy: fungal culture positive for Aspergillus
NR
Survived
18. Kazan 2011 [7]
24, F
NR
CML
NR, <0.5
Colon
NR
Laparotomy
Died at day 57
19. Kazan 2011 [7]
58, F
NR
ALL
NR, >0.5
Colon
Colonoscopy, culture positive for Aspergillus
NR
Survived
ALL acute lymphocytic leukemia, ANC absolute neutrophil count, AML acute myelogenous leukemia, CML chronic myelogenous leukemia, EGD esophagogastroduodenoscopy, G-CSF granulocyte colony stimulating factor, GI gastrointestinal, NR not reported, PBSCT peripheral blood stem cell transplantation, M male, F female, IV intravenous
aUnclear whether reported patient had isolated GI aspergillosis or disseminated infection
Literature
1.
go back to reference Erikci AA, Ozyurt M, Terekeci H, Ozturk A, Karabudak O, Oncu K. Oesophageal aspergillosis in a case of acute lymphoblastic leukaemia successfully treated with caspofungin alone due to liposomal amphotericin B induced severe hepatotoxicity. Mycoses. 2009;52:84–86. doi:10.1111/j.1439-0507.2008.01537.x.CrossRef Erikci AA, Ozyurt M, Terekeci H, Ozturk A, Karabudak O, Oncu K. Oesophageal aspergillosis in a case of acute lymphoblastic leukaemia successfully treated with caspofungin alone due to liposomal amphotericin B induced severe hepatotoxicity. Mycoses. 2009;52:84–86. doi:10.​1111/​j.​1439-0507.​2008.​01537.​x.CrossRef
2.
go back to reference Alioglu B, Avci Z, Canan O, Ozcay F, Demirhan B, Ozbek N. Invasive esophageal aspergillosis associated with acute myelogenous leukemia: successful therapy with combination caspofungin and liposomal amphotericin B. Pediatr Hematol Oncol. 2007;24:63–68.CrossRefPubMed Alioglu B, Avci Z, Canan O, Ozcay F, Demirhan B, Ozbek N. Invasive esophageal aspergillosis associated with acute myelogenous leukemia: successful therapy with combination caspofungin and liposomal amphotericin B. Pediatr Hematol Oncol. 2007;24:63–68.CrossRefPubMed
3.
go back to reference Bergman S, Geisinger KR. Esophageal aspergillosis in cytologic brushings: report of two cases associated with acute myelogenous leukemia. Diagn Cytopathol. 2004;30:347–349.CrossRefPubMed Bergman S, Geisinger KR. Esophageal aspergillosis in cytologic brushings: report of two cases associated with acute myelogenous leukemia. Diagn Cytopathol. 2004;30:347–349.CrossRefPubMed
4.
go back to reference Chionh F, Herbert KE, Seymour JF, et al. Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemia. Leuk Lymphoma. 2005;46:603–605.CrossRefPubMed Chionh F, Herbert KE, Seymour JF, et al. Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemia. Leuk Lymphoma. 2005;46:603–605.CrossRefPubMed
5.
go back to reference Choi JH, Yoo JH, Chung IJ, et al. Esophageal aspergillosis after bone marrow transplant. Bone Marrow Transplant. 1997;19:293–294.CrossRefPubMed Choi JH, Yoo JH, Chung IJ, et al. Esophageal aspergillosis after bone marrow transplant. Bone Marrow Transplant. 1997;19:293–294.CrossRefPubMed
6.
go back to reference Yoo JH, Shin WS, Kim YR, et al. Esophageal aspergillosis in a patient with acute leukemia. Leukemia. 1995;9:1599–1600.PubMed Yoo JH, Shin WS, Kim YR, et al. Esophageal aspergillosis in a patient with acute leukemia. Leukemia. 1995;9:1599–1600.PubMed
8.
go back to reference Eggimann P, Chevrolet JC, Starobinski M, et al. Primary invasive aspergillosis of the digestive tract: report of two cases and review of the literature. Infection. 2006;34:333–338.CrossRefPubMedPubMedCentral Eggimann P, Chevrolet JC, Starobinski M, et al. Primary invasive aspergillosis of the digestive tract: report of two cases and review of the literature. Infection. 2006;34:333–338.CrossRefPubMedPubMedCentral
9.
go back to reference Trésallet C, Nguyen-Thanh Q, Aubriot-Lorton MH, et al. Small-bowel infarction from disseminated aspergillosis. Dis Colon Rectum. 2004;47:1515–1518.CrossRefPubMed Trésallet C, Nguyen-Thanh Q, Aubriot-Lorton MH, et al. Small-bowel infarction from disseminated aspergillosis. Dis Colon Rectum. 2004;47:1515–1518.CrossRefPubMed
10.
go back to reference González-Vicent M, Díaz MA, Colmenero I, Sevilla J, Madero L. Primary gastrointestinal aspergillosis after autologous peripheral blood progenitor cell transplantation: an unusual presentation of invasive aspergillosis. Transpl Infect Dis. 2008;10:193–196.CrossRefPubMed González-Vicent M, Díaz MA, Colmenero I, Sevilla J, Madero L. Primary gastrointestinal aspergillosis after autologous peripheral blood progenitor cell transplantation: an unusual presentation of invasive aspergillosis. Transpl Infect Dis. 2008;10:193–196.CrossRefPubMed
11.
go back to reference Marterre WF Jr, Mong AT, Pulito AR. Locally invasive aspergillosis of the bowel. J Pediatr Surg. 1992;27:1611–1613.CrossRefPubMed Marterre WF Jr, Mong AT, Pulito AR. Locally invasive aspergillosis of the bowel. J Pediatr Surg. 1992;27:1611–1613.CrossRefPubMed
13.
go back to reference Denning DW. Aspergillosis. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J, eds. Harrison’s principles of internal medicine. 19th ed. New York: McGraw-Hill; 2015. Denning DW. Aspergillosis. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J, eds. Harrison’s principles of internal medicine. 19th ed. New York: McGraw-Hill; 2015.
Metadata
Title
Resolution of Isolated, Aspergillus Colonization in a Deep Esophageal Ulcer in an Immunocompetent Patient with Ulcer Healing Without Specific Antifungal Therapy
Authors
Mitchell S. Cappell
Dupinder Singh
Ross Sage
Mitual B. Amin
Publication date
01-08-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4101-x

Other articles of this Issue 8/2016

Digestive Diseases and Sciences 8/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine